🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

When I was a teacher the “trouble makers” sat in the back of the bus. -🤣

Catch up on the latest breakthroughs in #HemOnc with our expert-led Post-#EHA2025 Highlights webinars 📣💻📍European Hematology Association The #Myeloma session will be chaired by Faith E Davies & moderated by Charlotte Pawlyn & Ciara Freeman 🔗 REGISTER 👉 us06web.zoom.us/webinar/regist…

Mutagenic impact and evolutionary influence of chemo-radiotherapy in hematologic malignancies: brnw.ch/21wSRaV

Yes great job team

Elegant real-world study from Mayo Myeloma group showing that peak ALC >3K post-CAR infusion ➡️predictive biomarker for delayed neurotoxicity, enterocolitis, and CN palsy!! Simple, cheap, and scalable biomarker for designing interventions for primary prophylaxis targeting these

This is a really bad thing as the amyloid community really needs an antibody like this

Have to come all the way to Japan to see nizar jacques bahlis! So nice to see him at the excellent Japanese Society of Myeloma meeting this weekend. [with President of JSM Dr Iida in photo] #mmsm

The addition of daratumumab to CyBorD significantly improves hematological and organ response. ow.ly/ehYa50VVRNX #clinicaltrialsandobservations

The International Myeloma Working Group (IMWG) was formed in 2002 by International Myeloma Foundation bringing together myeloma experts committed to working together from around the world. IMWG.org Few diseases have a united collaborative group like this. The first papers were:

Gain valuable insights into the treatment of Waldenström’s macroglobulinemia from Steven Treon of Dana-Farber, who emphasizes the importance of staying up-to-date with the latest advances. Click here: 🎥 ow.ly/3YG450VWqlN #COMy2025 #Lymphoma #LYMsm #HemOnc COMy

📢 Positive CHMP opinion for two belantamab mafodotin combinations in relapsed/refractory #myeloma in Europe Read more 👇 mpeurope.org/ema-chmp-gives…

Interesting data we do very well with quads

Interesting new data on precursor conditions of mm

Great long term outcomes

Where’s my car; Sweet.

Significant new definitions of risk status in MM

#Myeloma Paper of the Day: Eagerly awaited new high-risk IMWG definition: 1. del 17p w/ >20% clonal frac &/or TP53 mut; 2. t(4;14), t(14;16), t(14;20) w/ 1q+ &/or del 1p32; 3. monoallelic del 1p32 w/ 1q+ or biallelic del 1p32; 4. β2 ≥5.5 & nl SCr: pubmed.ncbi.nlm.nih.gov/40489728/. #mmsm

Genomic landscape of multiple myeloma and its precursor conditions [May 21, 2025] Jean-Baptiste Alberge et al. Irene Ghobrial Nature Genetics nature.com/articles/s4158… #mmsm #PrecisionMedicine

Interesting for patients and doctors managing MM especially with newer agents